Project Number 5U01AG063768-02 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease. Research Categorization Primary Disease / Condition Vascular Dementia/Dysfunction CADRO Category C. Translational Research and Clinical Interventions Researcher and Organization Principal Investigator RODGERS, KATHLEEN E. Principal Investigator First Name KATHLEEN Principal Investigator Last Name RODGERS Awardee Organization UNIVERSITY OF ARIZONA Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-820: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) FY Overall Cost $1,531,012 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YUAN, JEAN
